Euromedis Groupe SA (ALEMG) - Cash Flow Conversion Efficiency

Latest as of June 2024: 0.036x

Based on the latest financial reports, Euromedis Groupe SA (ALEMG) has a cash flow conversion efficiency ratio of 0.036x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€796.00K ≈ $930.61K USD) by net assets (€22.06 Million ≈ $25.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALEMG defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Euromedis Groupe SA - Cash Flow Conversion Efficiency Trend (2009–2022)

This chart illustrates how Euromedis Groupe SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Euromedis Groupe SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Euromedis Groupe SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
MSCM Holdings Bhd KLSE:0041	-0.048x
Klimator AB ST:KLIMAT	0.368x
EcoBio Holdings Co. Ltd KQ:038870	0.027x
BALAXI PHARMACEUTICALS LIMITED NSE:BALAXI	0.063x
Mlk Foods Public Company Ltd WAR:MLK	0.004x
TCS Group Holdings Bhd KLSE:0221	-0.056x
Investsmart Group Ltd AU:INV	0.282x
In8bio Inc NASDAQ:INAB	-0.217x

Annual Cash Flow Conversion Efficiency for Euromedis Groupe SA (2009–2022)

The table below shows the annual cash flow conversion efficiency of Euromedis Groupe SA from 2009 to 2022. For the full company profile with market capitalisation and key ratios, see ALEMG market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	€34.88 Million ≈ $40.78 Million	€-1.05 Million ≈ $-1.23 Million	-0.030x	-106.44%
2021-12-31	€41.24 Million ≈ $48.21 Million	€19.25 Million ≈ $22.50 Million	0.467x	+34.56%
2020-12-31	€38.93 Million ≈ $45.51 Million	€13.50 Million ≈ $15.79 Million	0.347x	+534.61%
2019-12-31	€17.66 Million ≈ $20.64 Million	€965.00K ≈ $1.13 Million	0.055x	+171.22%
2018-12-31	€21.26 Million ≈ $24.86 Million	€-1.63 Million ≈ $-1.91 Million	-0.077x	-274.87%
2017-12-31	€27.80 Million ≈ $32.50 Million	€1.22 Million ≈ $1.43 Million	0.044x	-12.74%
2016-12-31	€28.81 Million ≈ $33.68 Million	€1.45 Million ≈ $1.69 Million	0.050x	-44.13%
2015-12-31	€28.60 Million ≈ $33.44 Million	€2.58 Million ≈ $3.01 Million	0.090x	-33.19%
2014-12-31	€25.58 Million ≈ $29.91 Million	€3.45 Million ≈ $4.03 Million	0.135x	+31.20%
2013-12-31	€23.42 Million ≈ $27.38 Million	€2.40 Million ≈ $2.81 Million	0.103x	-53.88%
2012-12-31	€21.25 Million ≈ $24.85 Million	€4.73 Million ≈ $5.53 Million	0.223x	+419.33%
2011-12-31	€20.18 Million ≈ $23.59 Million	€865.00K ≈ $1.01 Million	0.043x	-80.00%
2010-12-31	€18.35 Million ≈ $21.46 Million	€3.93 Million ≈ $4.60 Million	0.214x	+166.57%
2009-12-31	€17.52 Million ≈ $20.49 Million	€-5.64 Million ≈ $-6.60 Million	-0.322x	--

About Euromedis Groupe SA

PA:ALEMG France Medical Distribution

Market Cap

$17.03 Million

€14.57 Million EUR

Market Cap Rank

#26165 Global

#437 in France

Share Price

€5.10

Change (1 day)

+4.08%

52-Week Range

€3.83 - €5.75

All Time High

€24.90